Presentation THT 2026 HeartCon: Pioneering VAD Development in China Presenter: Xiaocheng Liu March 02, 2026 REGISTER for free or LOG IN to view this content THT 2026 Up Next Presentation THT 2026 YES: TEER is Totally Appropriate for Patients With Moderate MR if HF Presenter: Stefan Anker March 02, 2026 More slides + Presentation THT 2026 Antagonist: Deep Phenotyping and Phenomapping Has Been and Will Continue to Be A Mirage in Understanding the Mechanisms and Tailoring Treatment for HFpEF. Presenter: Milton Packer March 02, 2026 Presentation THT 2026 Case Presentation Presenter: Matthew Lawlor March 02, 2026 We Recommend Disclosures <p>Nothing to disclose</p>
Presentation THT 2026 YES: TEER is Totally Appropriate for Patients With Moderate MR if HF Presenter: Stefan Anker March 02, 2026
Presentation THT 2026 Antagonist: Deep Phenotyping and Phenomapping Has Been and Will Continue to Be A Mirage in Understanding the Mechanisms and Tailoring Treatment for HFpEF. Presenter: Milton Packer March 02, 2026